Skip to main content
Equibles

Schonfeld Strategic Advisors LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 1665241 NEW YORK, NY
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$56,811
-$538,189 QoQ
Shares Held
13,399
-68.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 103 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. BCYC ranks #123 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 697,586 $66,096,273
2 AGIO
Agios Pharmaceuticals, Inc.
 520,083 $19,300,280
3 JAZZ
Jazz Pharmaceuticals plc
 77,272 $18,620,233
4 VRDN
Viridian Therapeutics, Inc.\DE
 793,508 $14,576,741
5 MBX
MBX Biosciences, Inc.
 248,670 $13,726,584
6 XENE
Xenon Pharmaceuticals Inc.
 227,330 $13,721,638
7 PTCT
Ptc Therapeutics, Inc.
 147,425 $12,025,457
8 INSM
INSMED Inc
 104,378 $11,128,782

All Filings in BCYC

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,811 13,399
2024-12-31 $595,000 42,500
2024-09-30 $9,572,490 423,000
2024-06-30 $3,186,545 157,438
2024-03-31 $10,477,920 420,800
2023-12-31 $1,934,560 107,000
2023-09-30 $1,046,689 52,100
2023-06-30 $1,686,872 66,100
2023-03-31 $1,278,327 60,100
2022-12-31 $2,360,481 79,746
2022-09-30 $483,808 20,800
2022-06-30 $357,414 21,300
2022-03-31 $351,040 8,000
2021-09-30 $2,494,235 59,972
2021-06-30 $1,665,610 54,862
2021-03-31 $331,557 11,100